New hope for Tough-to-Treat leukemia: experimental drug enters human trials

NCT ID NCT07109219

Recruiting now Disease control Sponsor: AstraZeneca Source: ClinicalTrials.gov ↗

Summary

This study is testing a new drug called AZD4512 for people with B-cell acute lymphoblastic leukemia (B-ALL) that has come back or hasn't responded to other treatments. The main goals are to find a safe dose and see if the drug can help patients achieve remission. The study will enroll about 83 people aged 12 and older.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Research Site
RECRUITING

Duarte, California, 91010, United States
Research Site
WITHDRAWN

Jacksonville, Florida, 32224, United States
Research Site
NOT_YET_RECRUITING

Chicago, Illinois, 60611, United States
Research Site
RECRUITING

Iowa City, Iowa, 52242, United States
Research Site
RECRUITING

Franklin, Tennessee, 37067, United States
Research Site
RECRUITING

Houston, Texas, 77030, United States
Research Site
RECRUITING

Melbourne, 3000, Australia
Research Site
NOT_YET_RECRUITING

Vancouver, British Columbia, V5Z 1M9, Canada
Research Site
RECRUITING

Toronto, Ontario, M5G 1X6, Canada
Research Site
NOT_YET_RECRUITING

Guangzhou, 510515, China
Research Site
NOT_YET_RECRUITING

Tianjin, 301600, China
Research Site
RECRUITING

Bunkyō City, 113-8677, Japan
Research Site
RECRUITING

Chūōku, 104-0045, Japan
Research Site
RECRUITING

Seoul, 03080, South Korea
Research Site
RECRUITING

Seoul, 06351, South Korea
Research Site
RECRUITING

Seoul, 06591, South Korea
Research Site
RECRUITING

Seoul, 3722, South Korea
Research Site
NOT_YET_RECRUITING

Badalona(Barcelona), 08916, Spain
Research Site
RECRUITING

Barcelona, 08035, Spain
Research Site
RECRUITING

Salamanca, 37007, Spain
Research Site
RECRUITING

Santander, 39008, Spain
Research Site
WITHDRAWN

Valencia, 46026, Spain
Research Site
RECRUITING

Taichung, 40705, Taiwan
Research Site
RECRUITING

Taipei, 106, Taiwan
Research Site
RECRUITING

Bloomsbury, W1T 7HA, United Kingdom
Research Site
RECRUITING

Manchester, M20 4BX, United Kingdom

Conditions

Explore the condition pages connected to this study.

B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL)